Antigen-specific CD8+ effector T cells subjected to transient glucose restriction (TGR) displayed enhanced tumour clearance in a mouse model of lymphoma, with an increase in the number of donor CD8+ T cell in circulation that persisted up to 20 days after adoptive transfer. The gene discussed is CD8A; the disease is lymphoma.